26th International Symposium on Molecular Medicine


11-13 May 2023


Grand Hotel Duca D'Este, Tivoli, Rome, Italy





Presentations Include:


The list is incomplete and will be updated periodically:



  • Fabio Stefano Timeus - (Italy) - Hemophagocytic lymphohistiocytosis in clinical practice: 18 years of experience of the Onco-Hematology Department of Regina Margherita Children's Hospital.
  •  
  • Annette Kaiser - (Germany) - The molecular basis of hypusination in Plasmodium.
  •  
  • Jessica Gasparello - (Italy) - From Liquid Biopsy to microRNA Therapeutics for Colorectal Cancer (CRC).
  •  
  • Roberto Gambari - (Italy) - Expression of gamma-globin genes in sirolimus-treated beta-thalassemia patients.
  •  
  • Roberto Gambari - (Italy) - Inhibitory effects of SARS-CoV-2 Spike protein and BNT162b2 vaccine on erythropoietin-induced globin gene expression in erythroid precursor cells (ErPCs) from β-thalassemia patients.
  •  
  • Alessia Finotti - (Italy) - The Cystic Transmembrane Conductance Regulator Gene (CFTR) is under post-transcriptional control of microRNAs: effects of treatments with agomiRNAs and possible biomedical applicationss.
  •  
  • Alessia Finotti - (Italy) - Inhibition of the expression of pro-inflammatory genes by pre-miR-93-5p: relevance for Cystic Fibrosis and COVID-19.
  •  
  • Lisheng Wang - (Canada) - A drug nanotherapy to target breast cancer cells and cancer stem cells.
  •  
  • Maxim Khomutov - (Russia) - C-Methylated analogues of spermidine: synthesis and biological application.
  •  
  • Peter Nielsen - (Denmark) - New weapons against multidrug resisten bacterial infections.
  •  
  • Vlasta Galova - (Slovakia) - The sweet side of wound healing: galectins as promising therapeutic targets in the treatment of open excisions and sutured incisions.
  •  
  • Peter Gal - (Slovakia) - Novel approaches to treat wounds.
  •  
  • Tomas Vasilenko - (Slovakia) - Agrimonia eupatoria L. and skin wound healing.
  •  
  • Xing Cui - (China) - LncRNA MALAT1, Post-transcriptionally Stabilized by NSUN2-mediated M5C Modification, Exerts Properties in Bone Lesions Formation in Multiple Myeloma.
  •  
  • Esther Priel - (Israel) - The beneficial effects of novel telomerase increasing compounds on neurodegenerative and ageing related diseases.
  •  
  • Hamid Al-Jamal - (Malaysia) - Thymoquinone enhances Hypomethylation of SHP-1 and Inhibits JAK/STAT Signaling Pathway in K562 Chronic Myeloid Leukemia Cells.
  •  
  • Hsiao-Sheng Liu - (Taiwan) - Autophagy promotes insulin secretion under glucose stimulation both in vitro and in vivo in a RAB37 dependent manner.
  •  
  • Marianna Nicoletta Rossi - (Italy) - Identification and characterization of Kunitz-Type Protease Inhibitors from Blister Beetles trascriptomic analysis.
  •  
  • Matus Coma - (Slovakia) - Canonical and Non-canonical Transforming Factor-Beta Signaling in Fibroblasts Isolated from Various Neoplastic/Healing/Normal Tissues.
  •  
  • Alaiya Ayodele - (Saudi Arabia) - Dental Pulp MSCs from Osteopetrosis patients treated with the Carbonic anhydrase activator- azole stimulate osteogenic and immune metabolic pathways.
  •  
  • Lukas Urban - (Slovakia) - Comparison of Specific Myo/fibroblast Markers in Fibroblasts Isolated from Various Neoplastic/Healing/Normal Tissues.
  •  
  • Catia Mio - (Italy) - A C-Terminal Extension (CTE) variant affecting PAX6 transcriptional activity.
  •  
  • Nunzia Mollo - (Italy) - Mitochondrial dysfunction in Down syndrome is caused by an alteration in the NRIP1/PGC-1α pathway and occurs early during neuronal differentiation.
  •  
  • Michele Ammendola - (Italy) - Microenvironment, Immune Stromal Cells, Angio and Lymphoangiogenesis in Gastrointestinal Cancer Patients Undergoing Surgery.
  •  





    Back to Top